Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,072 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combinations of PBPs and MurM protein variants in early and contemporary high-level penicillin-resistant Streptococcus pneumoniae isolates in Spain.
del Campo R, Cafini F, Morosini MI, Fenoll A, Liñares J, Alou L, Sevillano D, Cantón R, Prieto J, Baquero F; Spanish Pneumococcal Network (G3/103). del Campo R, et al. Among authors: prieto j. J Antimicrob Chemother. 2006 May;57(5):983-6. doi: 10.1093/jac/dkl083. Epub 2006 Mar 13. J Antimicrob Chemother. 2006. PMID: 16533824
Bactericidal activity of moxifloxacin against multidrug-resistant Streptoccocus pneumoniae at clinically achievable serum and epithelial lining fluid concentrations compared with three other antimicrobials.
Cafini F, Alou L, Sevillano D, Valero E, Prieto J; Spanish Pneumococcal Infection Study Network (G03/103). Cafini F, et al. Among authors: prieto j. Int J Antimicrob Agents. 2004 Oct;24(4):334-8. doi: 10.1016/j.ijantimicag.2004.04.015. Int J Antimicrob Agents. 2004. PMID: 15380257
Bactericidal activity of amoxicillin against non-susceptible Streptococcus pneumoniae in an in vitro pharmacodynamic model simulating the concentrations obtained with the 2000/125 mg sustained-release co-amoxiclav formulation.
Sevillano D, Calvo A, Giménez MJ, Alou L, Aguilar L, Valero E, Carcas A, Prieto J. Sevillano D, et al. Among authors: prieto j. J Antimicrob Chemother. 2004 Dec;54(6):1148-51. doi: 10.1093/jac/dkh463. Epub 2004 Oct 15. J Antimicrob Chemother. 2004. PMID: 15489246
Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
Alou L, Aguilar L, Sevillano D, Giménez MJ, Cafini F, Valero E, Relaño MT, Prieto J. Alou L, et al. Among authors: prieto j. J Antimicrob Chemother. 2006 Apr;57(4):714-9. doi: 10.1093/jac/dkl041. Epub 2006 Feb 21. J Antimicrob Chemother. 2006. PMID: 16492718
A pharmacodynamic approach to antimicrobial activity in serum and epithelial lining fluid against in vivo-selected Streptococcus pneumoniae mutants and association with clinical failure in pneumonia.
Alou L, Giménez MJ, Sevillano D, Aguilar L, Cafini F, Echeverría O, Pérez-Trallero E, Prieto J. Alou L, et al. Among authors: prieto j. J Antimicrob Chemother. 2006 Aug;58(2):349-58. doi: 10.1093/jac/dkl250. Epub 2006 Jun 16. J Antimicrob Chemother. 2006. PMID: 16782744
Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different {beta}-lactams: an in vitro pharmacodynamic approach.
González N, Aguilar L, Alou L, Giménez MJ, Sevillano D, Torrico M, Cafini F, Coronel P, Prieto J. González N, et al. Among authors: prieto j. J Antimicrob Chemother. 2009 Jun;63(6):1215-22. doi: 10.1093/jac/dkp097. Epub 2009 Mar 22. J Antimicrob Chemother. 2009. PMID: 19307171
2,072 results